800
Participants
Start Date
March 10, 2025
Primary Completion Date
September 27, 2028
Study Completion Date
September 27, 2029
EsoCheck
FDA-approved, non-endoscopic, encapsulated swallowable balloon. EsoCheck will produce a sample which will subsequently be tested with EsoGuard assay. The EsoCheck is performed and completed in approximately 5 minutes.
EsoGuard
Approved laboratory, methylated DNA panel that detects esophageal neoplasia. The EsoGuard assay tests the EsoCheck samples to detect BE in GERD participants.
NOT_YET_RECRUITING
Johns Hopkins Hospital, Baltimore
RECRUITING
University Hospitals Cleveland Medical Center, Cleveland
NOT_YET_RECRUITING
Cleveland Clinic Taussig Cancer Center, Cleveland
NOT_YET_RECRUITING
University of Colorado, Aurora
NOT_YET_RECRUITING
University of North Carolina at Chapel Hill, Chapel Hill
Case Comprehensive Cancer Center
OTHER